Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
The Journal of Experimental Medicine
|
April 2, 2008
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity
Elizabeth E Forbes, Katherine Groschwitz, J Pablo Abonia, et al.
Genome Medicine
|
November 2, 2016
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease
Minghui Wang, Panos Roussos, Andrew McKenzie, et al.
Science Translational Medicine
|
October 3, 2014
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation
Janine Beale, Annabelle Jayaraman, David J Jackson, et al.
Addiction (Abingdon, England)
|
June 2, 2018
Texting to Reduce Alcohol Misuse (TRAM): main findings from a randomized controlled trial of a text message intervention to reduce binge drinking among disadvantaged men
Iain K Crombie, Linda Irvine, Brian Williams, et al.
Science Translational Medicine
|
February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase
Rachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Nature
|
September 4, 2020
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease
Ji-Yeun Hur, Georgia R Frost, Xianzhong Wu, et al.
Nature Neuroscience
|
August 21, 2019
Stress resilience is promoted by a Zfp189-driven transcriptional network in prefrontal cortex
Zachary S Lorsch, Peter J Hamilton, Aarthi Ramakrishnan, et al.
Plos One
|
November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial
Tufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One
|
October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
Christos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One
|
August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Alvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
The Journal of Experimental Medicine
|
April 2, 2008
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity
Elizabeth E Forbes, Katherine Groschwitz, J Pablo Abonia, et al.
Genome Medicine
|
November 2, 2016
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease
Minghui Wang, Panos Roussos, Andrew McKenzie, et al.
Science Translational Medicine
|
October 3, 2014
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation
Janine Beale, Annabelle Jayaraman, David J Jackson, et al.
Addiction (Abingdon, England)
|
June 2, 2018
Texting to Reduce Alcohol Misuse (TRAM): main findings from a randomized controlled trial of a text message intervention to reduce binge drinking among disadvantaged men
Iain K Crombie, Linda Irvine, Brian Williams, et al.
Science Translational Medicine
|
February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase
Rachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Nature
|
September 4, 2020
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease
Ji-Yeun Hur, Georgia R Frost, Xianzhong Wu, et al.
Nature Neuroscience
|
August 21, 2019
Stress resilience is promoted by a Zfp189-driven transcriptional network in prefrontal cortex
Zachary S Lorsch, Peter J Hamilton, Aarthi Ramakrishnan, et al.
Plos One
|
November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial
Tufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One
|
October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
Christos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One
|
August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Alvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Page
of 7